Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Hankerchiefon Jan 02, 2020 2:23pm

117 Views

Post# 30511999

RE:RE:RE:Phase 2 challenges

Justforfun10 wrote: Thanks for the info Macer. Still wondering if they can treat UUTUC while treating NMIBC with the same therapy. Is this not physically possible or is the immune response the only way to address this issue? Regardless, anyone with low stage bladder cancer that has not spread can have great hope of a complete cure.

Justforfun.....just imagine giving tld 1433 intervenously and then a day or so later treating the patient with laser or xray (after the tld 1433 has be taken up by cancer cells). Just think of all the differen t types of cancer that could be treated with this technique. I can't wait to see that.

Bullboard Posts

Rick Rule’s election insights: Gold, USD, and Canadian gas